Advertisement

Topics

Abpro Company Profile

01:28 EDT 16th June 2019 | BioPortfolio


News Articles [11 Associated News Articles listed on BioPortfolio]

Abpro, NJCTTQ partner to develop multiple bispecific antibody therapies

The collaboration leverages Abpro’s proprietary DiversImmuneTM antibody discovery platform. Under  the  terms  of  the  agreement,  Abpro  is  eligible to  receive up  to  $4  billion, ...

Abpro pens $4bn bispecific antibody deal with NJCTTQ

Abpro and Nanjing Chia Tai Tianqing Pharmaceutical Co. Ltd. (NJCTTQ; a division of Chia Tai Tianqing Pharmaceutical Group Co. Ltd.) will work together to discover and develop bispecific antibodies for...

Nanjing's NJCTTQ Signs $4 Billion In-Licensing Deal for Bi-Specific Immunotherapies from Abpro

NJCTTQ, a Nanjing pharma, announced a deal worth up to $4 billion to co-develop bispecific immunotherapies discovered by Abpro of Massachusetts. NJCTTQ will have China and Thai rights to multiple immu...

$4bn collaboration sees Abpro expand its global capabilities

Abpro and NJCTTQ enter $4bn agreement to develop bispecific antibody therapies for immuno-oncology and extend its global reach.

Abpro: Creating novel, breakthrough medicines.

Abpro have streamlined all aspects of the process to create a state-of-the-art gene-to-antibody platform that allows rapid generation of antibodies against previously difficult targets. Applications i...

Abpro and China's NJCTTQ Ink $4 Billion Development Deal

Abpro, based in Woburn, Mass., inked a deal worth up to $4 billion with China-based Nanjing Chia Tai Tianqing Pharmaceutical Company, known as NJCTTQ, a global pharmaceutical company.

Abpro, NJCTTQ to develop bispecific antibodies in immuno-oncology

Abpro and NJCTTQ Enter Into Partnership for Development of Multiple Novel Bispecific Antibodies

Abpro eligible to receive up to $4 billion, including $60 million in near-term R&D funding, plus potential milestones and royaltiesCollaboration to result in multiple new immuno-oncology bispecif...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "Abpro" on BioPortfolio

We have published hundreds of Abpro news stories on BioPortfolio along with dozens of Abpro Clinical Trials and PubMed Articles about Abpro for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Abpro Companies in our database. You can also find out about relevant Abpro Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record